BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15714971)

  • 1. [Histopathological features of prostate cancer].
    Kozuka Y; Imai H; Yamanaka M; Kozuka M; Uchida K; Shiraishi T
    Nihon Rinsho; 2005 Feb; 63(2):231-6. PubMed ID: 15714971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Benign mimickers of the prostate cancer. Diagnostic challenges].
    Compérat E; Varinot J; Srigley JR
    Ann Pathol; 2013 Aug; 33(4):237-46. PubMed ID: 23954116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of limited adenocarcinoma of the prostate.
    Epstein JI
    Histopathology; 2012 Jan; 60(1):28-40. PubMed ID: 22212076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.
    Borboroglu PG; Sur RL; Roberts JL; Amling CL
    J Urol; 2001 Sep; 166(3):866-70. PubMed ID: 11490235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate.
    Montironi R; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M
    Nat Clin Pract Urol; 2007 Jun; 4(6):321-32. PubMed ID: 17551536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal adenocarcinoma in prostate needle biopsy tissue.
    Thorson P; Humphrey PA
    Am J Clin Pathol; 2000 Dec; 114(6):896-909. PubMed ID: 11338479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
    Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
    Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preneoplastic lesions of the prostate-clinical, pathological and molecular biological aspects.
    Nasir A; Copeland J; Gillespie JW; Chughtai OR; Andrawis R; Kaiser HE; Manyak MJ
    In Vivo; 2002; 16(6):557-66. PubMed ID: 12494901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
    Wang W; Sun X; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
    Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
    Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of alpha-methylacyl coenzyme A racemase immunohistochemistry in the diagnosis of prostate cancer: a review.
    Adley BP; Yang XJ
    Anal Quant Cytol Histol; 2006 Feb; 28(1):1-13. PubMed ID: 16566275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of prostate carcinoma in core needle biopsy--definition of minimal criteria for the diagnosis of cancer in biopsy material.
    Algaba F; Epstein JI; Aldape HC; Farrow GM; Lopez-Beltran A; Maksem J; Orozco RE; Pacelli A; Pisansky TM; Trias I
    Cancer; 1996 Jul; 78(2):376-81. PubMed ID: 8674022
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of adenocarcinoma in prostate needle biopsy tissue.
    Humphrey PA
    J Clin Pathol; 2007 Jan; 60(1):35-42. PubMed ID: 17213347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical stains for p63 and alpha-methylacyl-CoA racemase, versus a cocktail comprising both, in the diagnosis of prostatic carcinoma: a comparison of the immunohistochemical staining of 430 foci in radical prostatectomy and needle biopsy tissues.
    Hameed O; Sublett J; Humphrey PA
    Am J Surg Pathol; 2005 May; 29(5):579-87. PubMed ID: 15832080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH; Signoretti S; Loda M
    Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].
    Yu T; Zhu SX; Zheng S; Chen SP
    Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.